Nautilus Biotechnology, Inc.
NAUT
$1.04
$0.032.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 190.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.00K | -- | -- | -- | -- |
| Cost of Revenue | 15.00K | -- | -- | -- | -- |
| Gross Profit | 175.00K | -- | -- | -- | -- |
| SG&A Expenses | 24.46M | 24.84M | 25.73M | 27.04M | 27.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.97M | 64.12M | 66.84M | 71.39M | 75.02M |
| Operating Income | -62.78M | -64.12M | -66.84M | -71.39M | -75.02M |
| Income Before Tax | -56.52M | -57.09M | -59.00M | -62.81M | -65.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.52 | -57.09 | -59.00 | -62.81 | -65.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.52M | -57.09M | -59.00M | -62.81M | -65.69M |
| EBIT | -62.78M | -64.12M | -66.84M | -71.39M | -75.02M |
| EBITDA | -61.35M | -62.50M | -65.08M | -69.53M | -73.07M |
| EPS Basic | -0.45 | -0.45 | -0.47 | -0.50 | -0.52 |
| Normalized Basic EPS | -0.28 | -0.28 | -0.29 | -0.31 | -0.33 |
| EPS Diluted | -0.45 | -0.45 | -0.47 | -0.50 | -0.52 |
| Normalized Diluted EPS | -0.28 | -0.28 | -0.29 | -0.31 | -0.33 |
| Average Basic Shares Outstanding | 506.44M | 505.51M | 505.02M | 504.45M | 503.60M |
| Average Diluted Shares Outstanding | 506.44M | 505.51M | 505.02M | 504.45M | 503.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |